Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C [clinicaltrials:NCT00120835]
Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C [clinicaltrials:NCT00120835]
Bio2RDF identifier
NCT00120835
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00120835
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
This study is being con ...... er with pegylated interferon.
brief title [clinicaltrials_vocabulary:brief-title]
Valopicitabine When Administer ...... aive Patients With Hepatitis C
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2005-07-11T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Genotype-1
Treatment-Naive
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2010-06-09T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00120835
official title [clinicaltrials_vocabulary:official-title]
An Open-Label, Multiple-Dose S ...... Genotype-1 Chronic Hepatitis C
org study id [clinicaltrials_vocabulary:org-study-id]
NV-08A-003
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2004-07-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2010-06-01T00:00:00Z
identifier
clinicaltrials:NCT00120835
title
Valopicitabine When Administer ...... aive Patients With Hepatitis C
@en
type
label
Valopicitabine When Administer ...... C [clinicaltrials:NCT00120835]
@en